Structural Basis for the Synthesis of Indirubins as Potent and Selective Inhibitors of Glycogen Synthase Kinase-3 and Cyclin-Dependent Kinases-Reference-Cited by-同舟云学术

Structural Basis for the Synthesis of Indirubins as Potent and Selective Inhibitors of Glycogen Synthase Kinase-3 and Cyclin-Dependent Kinases

Published:2004-01-08 Issue:4 Volume:47 Page:935-946
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Polychronopoulos Panagiotis¹,Magiatis Prokopios¹,Skaltsounis Alexios-Leandros¹,Myrianthopoulos Vassilios¹,Mikros Emmanuel¹,Tarricone Aldo¹,Musacchio Andrea¹,Roe S. Mark¹,Pearl Laurence¹,Leost Maryse¹,Greengard Paul¹,Meijer Laurent¹

Affiliation:

1. Laboratory of Pharmacognosy and Laboratory of Pharmaceutical Chemistry, Department of Pharmacy, University of Athens, Panepistimiopolis Zografou, GR-15771 Athens, Greece, Structural Biology Unit, Department of Experimental Oncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milano, Italy, 3, Centre for Structural Biology, Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London SW3 6JB, U.K., C.N.R.S., Cell Cycle Group, Station Biologique, B.P. 74, 29682 ROSCOFF...

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm031016d

Reference54 articles.

1. The role of protein phosphorylation in human health and disease.

2. Protein kinases — the major drug targets of the twenty-first century?

3. ATP site-directed competitive and irreversible inhibitors of protein kinases

4. Protein kinase inhibitors: emerging pharmacophores 1997 - 2000

Cited by 351 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxindole–benzothiazole hybrids as CDK2 inhibitors and anticancer agents: design, synthesis and biological evaluation;BMC Chemistry;2024-09-13

2. Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment;Current Medicinal Chemistry;2024-09

3. Evolving significance of kinase inhibitors in the management of Alzheimer's disease;European Journal of Pharmacology;2024-09

4. Design, synthesis, antineoplastic activity of new pyrazolo[3,4-d]pyrimidine derivatives as dual CDK2/GSK3β kinase inhibitors; molecular docking study, and ADME prediction;Bioorganic Chemistry;2024-09

5. Benzimidazole‐oxindole hybrids: A novel class of selective dual CDK2 and GSK‐3β inhibitors of potent anticancer activity;Archiv der Pharmazie;2024-07-23